Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

olikla s.r.o., kostelec nad Černými lesy array - 5562 moxifloxacin-hydrochlorid - oční kapky, roztok - 5mg/ml - moxifloxacin

Evropská unie - čeština - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Evropská unie - čeština - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriflunomid - roztroušená skleróza, relaps-remitentní - imunosupresiva, selektivní imunosupresiva - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

fresenius kabi s.r.o., praha array - 5562 moxifloxacin-hydrochlorid - infuzní roztok - 400mg/250ml - moxifloxacin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

farmaprojects s.a.u., barcelona ŠpanĚlsko - 5562 moxifloxacin-hydrochlorid - oční kapky, roztok - 5mg/ml - moxifloxacin

Evropská unie - čeština - EMA (European Medicines Agency)

viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - léky užívané při diabetu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 a 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17949 dapagliflozin - potahovaná tableta - 10mg - dapagliflozin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

zaklady farmaceutyczne polpharma sa, starogard gdański array - 17949 dapagliflozin - potahovaná tableta - 5mg - dapagliflozin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

aurovitas, spol. s r.o., praha array - 5562 moxifloxacin-hydrochlorid - potahovaná tableta - 400mg - moxifloxacin

Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

vivanta generics s.r.o., praha array - 5562 moxifloxacin-hydrochlorid - potahovaná tableta - 400mg - moxifloxacin